NCT06627998 Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer
| NCT ID | NCT06627998 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Cancer of Thyroid |
| Study Type | OBSERVATIONAL |
| Enrollment | 82 participants |
| Start Date | 2023-04-12 |
| Primary Completion | 2024-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 82 participants in total. It began in 2023-04-12 with a primary completion date of 2024-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a multicenter retrospective observational study aimed to evaluate the prevalence of osteo-metabolic complications in patients with thyroid cancer.
Eligibility Criteria
Inclusion Criteria: * age ≥ 18 years * Histological diagnosis of Thyroid Carcinoma * radiological data from chest x-ray in lateral projection in the preoperative evaluation on which the vertebral morphometry * Signing of the informed consent Exclusion Criteria: * Subjects not falling within the previously described criteria are excluded
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06627998 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer of Thyroid. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06627998 currently recruiting?
Yes, NCT06627998 is actively recruiting participants. Contact the research team at difilippo.luigi@hsr.it for enrollment information.
Where is the NCT06627998 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06627998 clinical trial?
NCT06627998 is sponsored by IRCCS San Raffaele. The trial plans to enroll 82 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.